GRI Bio, Inc. (GRI) Form 8-K — Nov 4, 2026
GRI Bio stockholders approved an amendment and restatement of the 2018 Equity Incentive Plan, increasing shares reserved by 546,529 and extending the evergreen provision to January 1, 2036, at the November 4, 2026 annual meeting. Stockholders also elected W. Marc Hertz and David Szekeres as Class III directors and ratified WithumSmith+Brown, PC as auditor for fiscal 2026. The quorum was 926,474 shares, about 42.37% of the 2,186,115 shares outstanding.
Key figures
- Shares Outstanding
- 2186115
- Quorum shares
- 926474
- Quorum percent
- 42.37%
- Iso limit shares
- 80000000
- Director comp limit
- $750,000 per fiscal year ($1,000,000 initial-service year)
- Evergreen extension
- January 1, 2036
- Plan share increase
- 546,529
- Evergreen annual increase
- lesser of 4% of shares outstanding or Board-determined amount
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.